Skip to main content
Erschienen in: Urolithiasis 4/2011

01.08.2011 | Original Paper

Difference in urinary stone components between obese and non-obese patients

verfasst von: Yii-Her Chou, Ching-Ming Su, Ching-Chia Li, Chia-Chu Liu, Mu-En Liu, Wen-Jeng Wu, Yung-Shun Juan

Erschienen in: Urolithiasis | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The prevalence and incidence of urinary stone disease have been reported to be associated with body weight and body mass index (BMI). The aim of the study was to determine the difference in stone components among different BMI groups in patients with urolithiasis. Between Dec 2005 and Jan 2008, 907 urinary calculi were collected and analyzed by infrared spectroscopy. Most of the stones had been passed spontaneously, and some were collected during surgical manipulations. The data on patients’ gender, age, BMI at diagnosis, and stone composition were collected. The patients were classified as normal weight (18.5≤ BMI <24), overweight (24≤ BMI <27), or obese (BMI ≥27). Of the 907 patients with urinary stone disease, 27.7% had normal weight, 33.5% were overweight, and 38.8% were obese. The prevalence of calcium oxalate stones in the normal weight, overweight, and obese groups were 23.1, 30.6, and 34.9%, respectively (P = 0.002), and the prevalence of uric acid stones in the different groups was 2.8, 7.2, and 7.7%, respectively (P = 0.002). The prevalence of calcium oxalate and uric acid stones, but not that of calcium phosphate stones, increased with body size. There was a significant correlation between BMI and uric acid stones in the overweight and obesity groups, with odds ratios of 3.28 and 4.35, respectively. The prevalence and incidence of urinary stone disease were found to be associated with BMI. The percentage of uric acid and calcium oxalate stones was higher in obese than in non-obese patients. There was no apparent difference in the prevalence of calcium phosphate stones between obese and non-obese patients.
Literatur
1.
Zurück zum Zitat Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC (2003) Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney Int 63:1817–1823PubMedCrossRef
2.
Zurück zum Zitat Johnson CM, Wilson DM, O′Fallon WM, Malek RS, Kurland LT (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16:624–631PubMedCrossRef Johnson CM, Wilson DM, O′Fallon WM, Malek RS, Kurland LT (1979) Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int 16:624–631PubMedCrossRef
3.
Zurück zum Zitat Yoshida O, Terai A, Ohkawa, Okada Y (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904PubMedCrossRef Yoshida O, Terai A, Ohkawa, Okada Y (1999) National trend of the incidence of urolithiasis in Japan from 1965 to 1995. Kidney Int 56:1899–1904PubMedCrossRef
4.
Zurück zum Zitat Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ (1998) Body size and risk of kidney stones. J Am Soc Nephrol 9:1645–1652PubMed
5.
Zurück zum Zitat Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults 1999–2000. JAMA 288:1723–1727PubMedCrossRef Flegal KM, Carroll MD, Ogden CL, Johnson CL (2002) Prevalence and trends in obesity among US adults 1999–2000. JAMA 288:1723–1727PubMedCrossRef
6.
Zurück zum Zitat Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMed Kopelman PG (2000) Obesity as a medical problem. Nature 404:635–643PubMed
7.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef Taylor EN, Stampfer MJ, Curhan GC (2005) Obesity, weight gain, and the risk of kidney stones. JAMA 293:455–462PubMedCrossRef
8.
Zurück zum Zitat Choo V (2002) WHO reassesses appropriate body-mass index for Asian populations. Lancet 360:235PubMedCrossRef Choo V (2002) WHO reassesses appropriate body-mass index for Asian populations. Lancet 360:235PubMedCrossRef
9.
Zurück zum Zitat Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152PubMedCrossRef Coe FL, Parks JH, Asplin JR (1992) The pathogenesis and treatment of kidney stones. N Engl J Med 327:1141–1152PubMedCrossRef
10.
Zurück zum Zitat Levy FL, Adams-Huet B, Pak CY (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98:50–59PubMedCrossRef Levy FL, Adams-Huet B, Pak CY (1995) Ambulatory evaluation of nephrolithiasis: an update of a 1980 protocol. Am J Med 98:50–59PubMedCrossRef
11.
Zurück zum Zitat Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ (2008) Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol 179:570–574PubMedCrossRef Lee SC, Kim YJ, Kim TH, Yun SJ, Lee NK, Kim WJ (2008) Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence. J Urol 179:570–574PubMedCrossRef
12.
Zurück zum Zitat Sarica K, Altay B, Erturhan S (2008) Effect of being overweight on stone-forming risk factors. Urology 71:771–774PubMedCrossRef Sarica K, Altay B, Erturhan S (2008) Effect of being overweight on stone-forming risk factors. Urology 71:771–774PubMedCrossRef
13.
Zurück zum Zitat Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melquist J, Ikramuddin S et al (2008) Lithogenic risk factors in the morbidly obese population. J Urol 179:1401–1406PubMedCrossRef Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melquist J, Ikramuddin S et al (2008) Lithogenic risk factors in the morbidly obese population. J Urol 179:1401–1406PubMedCrossRef
14.
Zurück zum Zitat Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257–264PubMedCrossRef Obligado SH, Goldfarb DS (2008) The association of nephrolithiasis with hypertension and obesity: a review. Am J Hypertens 21:257–264PubMedCrossRef
15.
Zurück zum Zitat Zilberman DE, Yong D, Albala DM (2009) The impact of societal changes on patterns of urolithiasis. Curr Opin Urol 20:148–153CrossRef Zilberman DE, Yong D, Albala DM (2009) The impact of societal changes on patterns of urolithiasis. Curr Opin Urol 20:148–153CrossRef
17.
Zurück zum Zitat Eisner BH, Eisenberg ML, Stoller ML (2009) Influence of body mass index on quantitative 24-hour urine chemistry studies in children with nephrolithiasis. J Urol 182:1142–1145PubMedCrossRef Eisner BH, Eisenberg ML, Stoller ML (2009) Influence of body mass index on quantitative 24-hour urine chemistry studies in children with nephrolithiasis. J Urol 182:1142–1145PubMedCrossRef
18.
Zurück zum Zitat Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA et al (2007) Changing gender prevalence of stone disease. J Urol 177:979–982PubMedCrossRef Scales CD Jr, Curtis LH, Norris RD, Springhart WP, Sur RL, Schulman KA et al (2007) Changing gender prevalence of stone disease. J Urol 177:979–982PubMedCrossRef
19.
Zurück zum Zitat Strope SA, Wolf JS Jr, Hollenbeck BK (2009) Changes in gender distribution of urinary stone disease. Urology 75:543–546PubMedCrossRef Strope SA, Wolf JS Jr, Hollenbeck BK (2009) Changes in gender distribution of urinary stone disease. Urology 75:543–546PubMedCrossRef
20.
Zurück zum Zitat Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE et al (2005) Impact of body weight on urinary electrolytes in urinary stone former. Urology 55(6):825–830CrossRef Powell CR, Stoller ML, Schwartz BF, Kane C, Gentle DL, Bruce JE et al (2005) Impact of body weight on urinary electrolytes in urinary stone former. Urology 55(6):825–830CrossRef
21.
Zurück zum Zitat Li WM, Chou YH, Li CC, Liu CC, Huang SP, Wu WJ et al (2009) Association of body mass index and urine pH in patients with urolithiasis. Urol Res 37:193–196PubMedCrossRef Li WM, Chou YH, Li CC, Liu CC, Huang SP, Wu WJ et al (2009) Association of body mass index and urine pH in patients with urolithiasis. Urol Res 37:193–196PubMedCrossRef
22.
Zurück zum Zitat Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adam-Huet B, Pak CY (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65:1422–1425PubMedCrossRef Maalouf NM, Sakhaee K, Parks JH, Coe FL, Adam-Huet B, Pak CY (2004) Association of urinary pH with body weight in nephrolithiasis. Kidney Int 65:1422–1425PubMedCrossRef
23.
Zurück zum Zitat Sakhaee K, Maalouf NM (2008) Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol 28:174–180PubMedCrossRef Sakhaee K, Maalouf NM (2008) Metabolic syndrome and uric acid nephrolithiasis. Semin Nephrol 28:174–180PubMedCrossRef
24.
25.
Zurück zum Zitat Kamel KS, Cheema-Dhadli S, Halperin ML (2002) Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int 61:988–994PubMedCrossRef Kamel KS, Cheema-Dhadli S, Halperin ML (2002) Studies on the pathophysiology of the low urine pH in patients with uric acid stones. Kidney Int 61:988–994PubMedCrossRef
26.
Zurück zum Zitat Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K et al (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392PubMedCrossRef Abate N, Chandalia M, Cabo-Chan AV Jr, Moe OW, Sakhaee K et al (2004) The metabolic syndrome and uric acid nephrolithiasis: novel features of renal manifestation of insulin resistance. Kidney Int 65:386–392PubMedCrossRef
27.
Zurück zum Zitat Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033PubMedCrossRef Daudon M, Traxer O, Conort P, Lacour B, Jungers P (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033PubMedCrossRef
28.
Zurück zum Zitat Pak CY, Sakhaee K, Moe O, Preminger GM, Poindexter JR, Peterson RD et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523–527PubMedCrossRef Pak CY, Sakhaee K, Moe O, Preminger GM, Poindexter JR, Peterson RD et al (2003) Biochemical profile of stone-forming patients with diabetes mellitus. Urology 61:523–527PubMedCrossRef
29.
Zurück zum Zitat Grases F, Sanchis P, Perello J, Maser-Gluth C, Remer T (2006) Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol 13:252–256PubMedCrossRef Grases F, Sanchis P, Perello J, Maser-Gluth C, Remer T (2006) Role of uric acid in different types of calcium oxalate renal calculi. Int J Urol 13:252–256PubMedCrossRef
30.
Zurück zum Zitat Grover PK, Ryall RL (2005) Critical appraisal of salting-out and its implications for chemical and biological sciences. Chem Rev 105:1–10PubMedCrossRef Grover PK, Ryall RL (2005) Critical appraisal of salting-out and its implications for chemical and biological sciences. Chem Rev 105:1–10PubMedCrossRef
31.
Zurück zum Zitat Shi L, Berkemeyer S, Buyken AE, Maser-Gluth C, Remer T (2010) Glucocorticoids and body fat associated with renal uric acid and oxalate, but not calcium excretion, in healthy children. Metabolism 59(1):134–139PubMedCrossRef Shi L, Berkemeyer S, Buyken AE, Maser-Gluth C, Remer T (2010) Glucocorticoids and body fat associated with renal uric acid and oxalate, but not calcium excretion, in healthy children. Metabolism 59(1):134–139PubMedCrossRef
32.
Zurück zum Zitat Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I (2008) Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36:303–307PubMedCrossRef Negri AL, Spivacow FR, Del Valle EE, Forrester M, Rosende G, Pinduli I (2008) Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers. Urol Res 36:303–307PubMedCrossRef
Metadaten
Titel
Difference in urinary stone components between obese and non-obese patients
verfasst von
Yii-Her Chou
Ching-Ming Su
Ching-Chia Li
Chia-Chu Liu
Mu-En Liu
Wen-Jeng Wu
Yung-Shun Juan
Publikationsdatum
01.08.2011
Verlag
Springer-Verlag
Erschienen in
Urolithiasis / Ausgabe 4/2011
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-010-0344-8

Weitere Artikel der Ausgabe 4/2011

Urolithiasis 4/2011 Zur Ausgabe

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.